Viewing Study NCT05123950


Ignite Creation Date: 2025-12-24 @ 4:52 PM
Ignite Modification Date: 2025-12-29 @ 9:51 PM
Study NCT ID: NCT05123950
Status: COMPLETED
Last Update Posted: 2021-11-17
First Post: 2021-10-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module